{"id":232168,"date":"2020-11-30T08:00:43","date_gmt":"2020-11-30T08:00:43","guid":{"rendered":"https:\/\/eu.intelligentlabs.org\/priezastys-vartoti-mio-inozitoli\/"},"modified":"2025-09-23T00:22:50","modified_gmt":"2025-09-22T23:22:50","slug":"priezastys-vartoti-mio-inozitoli","status":"publish","type":"post","link":"https:\/\/eu.intelligentlabs.org\/lt-lt\/priezastys-vartoti-mio-inozitoli\/","title":{"rendered":"23 \u012ftikinan\u010dios prie\u017eastys prad\u0117ti vartoti mio-inozitolio papildus \u0161iandien"},"content":{"rendered":"\n<p>Laikais, kai tokiam dideliam moter\u0173 skai\u010diui diagnozuojamas PKS (policistini\u0173 kiau\u0161id\u017ei\u0173 sindromas), inozitolio populiarumas tapo kaip niekada didelis. Jis giriamas kaip VAISTAS, skirtas ken\u010dian\u010dioms nuo PKS bei kit\u0173 sveikatos sutrikim\u0173, bet ar jis tinkamas papildas jums?<\/p>\n\n\n\n<p>Ties\u0105 pasakius, tai tur\u0117tum\u0117te nuspr\u0119sti kartu su savo gydytoju. Bet, perskait\u0119 \u0161\u012f straipsn\u012f, su\u017einosite, kad inozitolis yra sveikas papildas, net kai vartojamas didesn\u0117mis doz\u0117mis. Skaitykite toliau ir su\u017einokite, kod\u0117l inozitolis (ir b\u016btent mio-inozitolis) yra maisto papildas, kur\u012f privalote i\u0161bandyti \u0161iandien.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Mio-inozitolis prie\u0161 inozitol\u012f: ar tai vienas ir tas pats?<\/strong><\/h2>\n\n\n\n<p>Visada, kai skait\u0117te ar gird\u0117jote \u017eod\u012f \u201einozitolis\u201c, i\u0161 ties\u0173 buvo kalbama apie \u201emio-inozitol\u012f\u201c. Taigi, inozitolis i\u0161 ties\u0173 yra 9 izomer\u0173 cukraus alkoholis. Tai rei\u0161kia, kad jis turi 9 atmainas arba formas, turin\u010dias tas pa\u010dias molekules, bet skirting\u0105 atom\u0173 i\u0161sid\u0117stym\u0105 (pa\u017evelkite \u012f \u017eemiau esant\u012f <a href=\"https:\/\/en.wikipedia.org\/wiki\/Inositol\" rel=\"noopener\">Wikipedia<\/a> paveiksl\u0117l\u012f).<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"734\" height=\"344\" src=\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-1.png\" alt=\"9 inozitolio izomerai\" class=\"wp-image-232030\" srcset=\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-1.png 734w, https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-1-300x141.png 300w, https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-1-600x281.png 600w\" sizes=\"auto, (max-width: 734px) 100vw, 734px\" \/><\/figure>\n<\/div>\n\n\n<p>Mio-inozitolis yra pati da\u017eniausia ir gausiausia inozitolio forma, o visos kitos randamos tik ma\u017eais kiekiais. \u0160tai tod\u0117l, kalbant apie inozitol\u012f, da\u017eniausiai i\u0161 ties\u0173 kalbama apie mio-inozitol\u012f.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>Nuo dabar kiekvien\u0105 kart\u0105 \u0161iame straipsnyje min\u0117dama inozitol\u012f, a\u0161 i\u0161 ties\u0173 kalb\u0117siu apie mio-inozitol\u012f.<\/p>\n<\/blockquote>\n\n\n\n<p>Inozitolis yra cukraus alkoholio forma, nat\u016braliai randama vaisiuose, rie\u0161utuose ir gr\u016bduose. M\u016bs\u0173 k\u016bnas taip pat gamina inozitol\u012f i\u0161 gliukoz\u0117s ir j\u012f naudoja \u012fvairi\u0173 biochemini\u0173 proces\u0173 metu. Dideli jo kiekiai randami m\u016bs\u0173 smegenyse ir kituose audiniuose. Be to, m\u016bs\u0173 inkstai kasdien pagamina apie 2 gramus inozitolio.<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"529\" src=\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-11-14-1024x529.jpeg\" alt=\"3 merginos, laukian\u010dios, kol gal\u0117s papasakoti mums nuostabi\u0173 dalyk\u0173 apie mio-inozitol\u012f\n\" class=\"wp-image-248769\" srcset=\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-11-14-1024x529.jpeg 1024w, https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-11-14-300x155.jpeg 300w, https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-11-14-768x397.jpeg 768w, https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-11-14-600x310.jpeg 600w, https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-11-14.jpeg 1200w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n<h2 class=\"wp-block-heading\"><strong>23 dalykai, kuriuos tur\u0117tum\u0117te \u017einoti apie inozitol\u012f<\/strong><\/h2>\n\n\n\n<p>Jei neapsisprend\u017eiate, ar tur\u0117tum\u0117te vartoti inozitol\u012f, ar galvojate, kod\u0117l jis toks svarbus daugeliui moter\u0173, skaitykite toliau ir su\u017einokite daugiau!<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>1) &nbsp; Inozitolis padeda valdyti PKS simptomus<\/strong><\/h3>\n\n\n\n<p>Vartojamas kartu su d-chiro-inozitoliu (vienu i\u0161 9 anks\u010diau min\u0117t\u0173 inozitolio izomer\u0173), mio-inozitolis gali pad\u0117ti valdyti PKS simptomus. Tarp j\u0173 ir akn\u0117, svorio augimas, hirsutizmas, moteri\u0161kas plikimas, nereguliarios menstruacijos ir kt. (daugiau apie tai, kaip inozitolis padeda suvaldyti \u0161iuos simptomus, papasakosiu v\u0117liau).<\/p>\n\n\n\n<p>Bet nevartokite bet kokio inozitolio papildo &#8211; ie\u0161kokite tokio, kuriame b\u016bt\u0173 naudojamas bent <strong>moksli\u0161kai rekomenduojamas 40:1 mio-inozitolio ir d-chiro-inozitolio santykis <\/strong>(1).<\/p>\n\n\n\n<p>Visgi, nors tyrim\u0173 duomenimis 40:1 santykis yra svarbus PKS simptom\u0173 gydymui, pacientams taip pat gali praversti ir kiti ingredientai, tokie kaip folatas ir chromas. D\u0117l \u0161ios prie\u017easties m\u016bs\u0173 <strong>Intelligent Labs Chromositol-F inozitolio papildo milteliuose moterims<\/strong> taip pat yra \u0161i\u0173 ingredient\u0173:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>40:1 mio-inozitolio (2000 mg) ir d-chiro-inozitolio (50 mg) mi\u0161inys<\/li>\n\n\n\n<li>200 \u00b5g folato (5-MTHF aktyvintos folato r\u016bg\u0161ties)<\/li>\n\n\n\n<li>200 \u00b5g chromo (pikolinato)<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>2) &nbsp; Jis pagerina jautrum\u0105 insulinui<\/strong><\/h3>\n\n\n\n<p>Insulinas kontroliuoja kraujo cukraus lyg\u012f kraujyje. Bet kai j\u016bs\u0173 k\u016bnas pradeda nereaguoti \u012f insulin\u0105, tai gali sukelti atsparum\u0105 insulinui. D\u0117l \u0161ios prie\u017easties gali i\u0161sivystyti diabetas, \u0161irdies ir kraujagysli\u0173 ligos, metabolinis sindromas ir kt.<\/p>\n\n\n\n<p>Pasak 2018 metais Tarptautiniame endokrinologijos \u017eurnale (International Journal of Endocrinology) publikuoto tyrimo, <strong>inozitolis gali pad\u0117ti normalizuoti kraujo cukraus lyg\u012f ir u\u017ekirsti keli\u0105 hiperinsulinemijai <\/strong>(per didelis insulino kiekis kraujyje). D\u0117l \u0161ios prie\u017easties, inozitolis tapo perspektyviu b\u016bdu spr\u0119sti jautrumo insulinui problem\u0105, ypa\u010d tarp PKS pacien\u010di\u0173 (2).&nbsp;<\/p>\n\n\n\n<p>D\u0117l \u0161io inozitolio privalumo m\u016bs\u0173 Chromositol-F papild\u0105 gali vartoti ir vyrai &#8211; jis padeda skatinti jautrum\u0105 insulinui!<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>3) &nbsp; Inozitolis padeda pagerinti moter\u0173 oocit\u0173 ar kiau\u0161in\u0117li\u0173 kokyb\u0119<\/strong><\/h3>\n\n\n\n<p>Li\u016bdna \u017einoti, ta\u010diau PKS pacient\u0117ms sunkiau susilaukti vaik\u0173. Nors reprodukcines problemas gali sukelti daugyb\u0117 skirting\u0173 prie\u017eas\u010di\u0173, viena j\u0173 yra moters kiau\u0161in\u0117li\u0173 kokyb\u0117. Suprantate, auk\u0161tesn\u0117s kokyb\u0117s kiau\u0161in\u0117liai turi geresn\u012f \u0161ans\u0105 <strong>i\u0161sivystyti \u012f embrion\u0105, \u012fsitvirtinti gimdoje<\/strong> ir, gal\u0173 gale, <strong>pad\u0117ti gimti sveikam k\u016bdikiui<\/strong>.<\/p>\n\n\n\n<p>Jei bandote pastoti, d\u017eiaugsit\u0117s \u017einodami, kad mio-inozitolio papild\u0173 vartojimas gali pagerinti PKS pacien\u010di\u0173 kiau\u0161in\u0117li\u0173 kokyb\u0119 (3). Bet tai dar ne viskas. <strong>Nustatyta, kad inozitolis ir folio r\u016bg\u0161tis (o ne tik folio r\u016bg\u0161tis) pagerina PKS sergan\u010di\u0173 moter\u0173 oocit\u0173 kokyb\u0119 <\/strong>(4).&nbsp;<\/p>\n\n\n\n<p>Kaip jau min\u0117ta 1 punkte, m\u016bs\u0173 Chromositol-F papilde yra abu kiau\u0161in\u0117li\u0173 kokyb\u0119 pagerinantys ingredientai &#8211; mio-inozitolis ir folio r\u016bg\u0161tis!<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>4) &nbsp; Jis padeda pagerinti vyr\u0173 spermos kokyb\u0119<\/strong><\/h3>\n\n\n\n<p>Jei j\u016bs\u0173 partneris turi vyri\u0161k\u0173 reprodukcini\u0173 problem\u0173, paskatinkite juos vartoti inozitolio papildus! Pasak 2016 m. atlikto tyrimo, kuriame dalyvavo 45 vyrai, ken\u010diantys nuo metabolinio sindromo, inozitolis (bei kitos maistin\u0117s med\u017eiagos, tokios kaip folio r\u016bg\u0161tis, vitaminas E ir selenas) pad\u0117jo vyrams pagerinti jautrum\u0105 insulinui ir padidino j\u0173 testosterono lygius. Bet svarbiausia, kad <strong>taip pat \u017eenkliai pager\u0117jo spermos koncentracija ir judrumas <\/strong>(5).&nbsp;<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"547\" src=\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-12-15-1024x547.jpeg\" alt=\"mio-inozitolis padeda pagerinti vyr\u0173 spermos kokyb\u0119\n\" class=\"wp-image-248796\" srcset=\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-12-15-1024x547.jpeg 1024w, https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-12-15-300x160.jpeg 300w, https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-12-15-768x410.jpeg 768w, https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-12-15-600x321.jpeg 600w, https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-12-15.jpeg 1200w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n<h3 class=\"wp-block-heading\"><strong>5) \u00a0 Pagerina PKS sergan\u010di\u0173 moter\u0173 vaisingum\u0105<\/strong><\/h3>\n\n\n\n<p>Dabar jau \u017einote, kad inozitolis gali pagerinti jautrum\u0105 insulinui, kuris sukelia teigiamus j\u016bs\u0173 k\u016bno poky\u010dius. Vieni j\u0173 &#8211; pastebimas svorio suma\u017e\u0117jimas (nes atsparumas insulinui gali sukelti svorio augim\u0105), atkurtas menstruacij\u0173 ciklas ir, \u017einoma, pager\u0117jusi kiau\u0161in\u0117li\u0173 kokyb\u0117. Visi \u0161ie veiksniai padeda pagerinti PKS pacien\u010di\u0173 vaisingum\u0105!<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>6) \u00a0 Inozitolis suma\u017eina testosterono lygius<\/strong><\/h3>\n\n\n\n<p>Vyr\u0173 hormonas n\u0117ra tik vyrams. Jis taip pat randamas ir moter\u0173 organizmuose, bet PKS sergan\u010di\u0173 moter\u0173 testosterono lygis yra auk\u0161tesnis nei \u012fprasta. D\u0117l to PKS sergan\u010dioms moterims gali atsirasti vyri\u0161k\u0173 bruo\u017e\u0173, toki\u0173 kaip moteri\u0161kas plikimas, perteklinis plauk\u0173 augimas nemoteri\u0161kose k\u016bno vietose, akn\u0117 ir menstruacij\u0173 ciklo sutrikimai.<\/p>\n\n\n\n<p>Simptomai gali labai paveikti moter\u0173 savivert\u0119. Laimei, inozitolis \u0161iuo klausimu atrodo labai perspektyvus. Klinikini\u0173 tyrim\u0173 metu tyr\u0117jai nustat\u0117, kad pacientus gydant <strong>galingu inozitolio ir folio r\u016bg\u0161ties deriniu, \u017eenkliai suma\u017e\u0117jo testosterono lygis<\/strong> (8)!<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>7) \u00a0 Inozitolis padeda atsikratyti hirsutizmo, dar \u017einomo kaip nepageidaujamas plaukuotumas<\/strong><\/h3>\n\n\n\n<p>Barzdotos moterys egzistuoja. Nors yra moter\u0173, kurios i\u0161moko susigyventi su \u0161ia problema, dauguma j\u0173 visi\u0161kai n\u0117ra patenkintos tokiu gyvenimu. Jei priklausote antrajai grupei, inozitolis yra geriausias j\u016bs\u0173 \u0161ansas atsikratant hirsutizmo visam likusiam gyvenimui!<\/p>\n\n\n\n<p>2018 m. atliktame tyrime 46 hirsutizmu sergan\u010dios moterys 6 m\u0117nesius vartojo mio-inozitol\u012f. Kaip jau turb\u016bt atsp\u0117jote, androgen\u0173 (vyri\u0161k\u0173 hormon\u0173) lygis suma\u017e\u0117jo, o estrogen\u0173 (moteri\u0161k\u0173 hormon\u0173) koncentracija i\u0161augo. Tai pad\u0117jo moterims <strong>pagaliau atsikratyti nepageidaujamo plauk\u0173 augimo <\/strong>(10).&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>8)\u00a0 Jis padeda suma\u017einti triglicerid\u0173 lyg\u012f<\/strong><\/h3>\n\n\n\n<p>Auk\u0161tas triglicerid\u0173 lygis gali padidinti insulto ir \u0161irdies lig\u0173 rizik\u0105. Dauguma \u017emoni\u0173 nejau\u010dia to simptom\u0173, iki kol trigliceridai pasiekia itin auk\u0161t\u0105 lyg\u012f. Daugumai tai gali b\u016bti per v\u0117lu.&nbsp;<\/p>\n\n\n\n<p>Vartodami inozitol\u012f, galite suma\u017einti triglicerid\u0173 lyg\u012f ir \u0161irdies ir kraujagysli\u0173 lig\u0173 rizik\u0105. Visa tai paremta 2018 m. sudaryta sistemine tyrim\u0173 ap\u017evalga, kuri atskleid\u0117, kad <strong>inozitolis i\u0161 ties\u0173 yra efektyvus suma\u017einant triglicerid\u0173 lyg\u012f iki normalaus <\/strong>(9).&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>9)\u00a0 Mio-inozitolis gali suma\u017einti MTL ir bendro cholesterolio lyg\u012f<\/strong><\/h3>\n\n\n\n<p>Tabrizi et al. atliktame tyrime (9) taip pat buvo nustatyta, kad inozitolis gali suma\u017einti MTL cholesterolio ir bendro cholesterolio lygius. MTL yra ma\u017eo tankio lipoprotein\u0173, arba \u201eblogasis\u201c cholesterolis. D\u0117l per didelio MTL lygio arterijose gali susidaryti apna\u0161os, kurios, kaip jau turb\u016bt supratote, rei\u0161kia blogas naujienas. U\u017esikim\u0161usi arterija gali greitai sukelti \u0161irdies sm\u016bg\u012f ar insult\u0105.&nbsp;<\/p>\n\n\n\n<p>Nors inozitolis niekaip nepaveikia DTL (didelio tankio lipoprotein\u0173) arba \u201egerojo\u201c cholesterolio, jis turi \u012ftak\u0105 bendram cholesterolio lygiui. Taigi, <strong>inozitolis yra suma\u017e\u0117jusio cholesterolio lygio ir geresn\u0117s j\u016bs\u0173 \u0161irdies sveikatos prana\u0161as!<\/strong><\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"623\" src=\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-14-9.jpeg\" alt=\"mio-inozitolis pagerina PKS sergan\u010di\u0173 moter\u0173 vaisingumo rodiklius\n\" class=\"wp-image-248823\" srcset=\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-14-9.jpeg 1024w, https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-14-9-300x183.jpeg 300w, https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-14-9-768x467.jpeg 768w, https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-14-9-600x365.jpeg 600w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n<h3 class=\"wp-block-heading\"><strong>10)\u00a0 Pad\u0117s i\u0161valyti j\u016bs\u0173 od\u0105<\/strong><\/h3>\n\n\n\n<p>Auk\u0161tas PKS pacien\u010di\u0173 testosterono lygis gali sukelti perteklin\u0119 riebal\u0173 gamyb\u0105. Jie gali u\u017ekim\u0161ti j\u016bs\u0173 poras ir sukelti akn\u0117s protr\u016bkius visame k\u016bne. Bet inozitolio galia normalizuoti testosterono lyg\u012f (punktas Nr. 9) taip pat gali pad\u0117ti jums atsikratyti akn\u0117s!&nbsp;<\/p>\n\n\n\n<p>Tai \u012frodo ir klinikin\u0117 studija, kurioje 50 moter\u0173, ken\u010dian\u010di\u0173 nuo vidutini\u0161kos b\u016bkl\u0117s akn\u0117s, kasdien vartojo 4 g inozitolio. Po 6 m\u0117nesi\u0173 pacien\u010di\u0173 DHEA-S lygis kraujyje (DHEA-S yra hormonas, gaminantis testosteron\u0105) buvo suma\u017e\u0117j\u0119s. <strong>Taip pat buvo nustatytas pacien\u010di\u0173 odos b\u016bkl\u0117s pager\u0117jimas. <\/strong>Tyr\u0117jai padar\u0117 i\u0161vad\u0105, kad inozitolis gali b\u016bti vartojamas gydant akn\u0119, o ypa\u010d kai pacien\u010di\u0173 negalima gydyti estrogeno-progestino terapija (11).<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>11)\u00a0 Inozitolis gali pad\u0117ti palengvinti depresij\u0105<\/strong><\/h3>\n\n\n\n<p>Kartkartin\u0117s li\u016bdnos mintys yra normalu. Bet kai jau\u010diat\u0117s, lyg ridenat\u0117s \u017eemyn be jokios vilties sustoti ar sk\u0119state li\u016bdesyje, tikriausiai sergate depresija. Pasak <a href=\"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression\" rel=\"noopener\">Pasaulio sveikatos organizacijos<\/a>, visame pasaulyje nuo depresijos ken\u010dia daugiau nei 264 milijon\u0173 \u017emoni\u0173.<\/p>\n\n\n\n<p>Depresijos gydymui \u012fprastai naudojama terapija ir vaistai. Bet inozitolis taip pat gali pad\u0117ti. Vieno tyrimo metu buvo stebimi 28 pacientai, kuriems 4 savaites kasdien buvo duodama 12 g inozitolio. Tyrimo pabaigoje <strong>pacientai pademonstravo \u017eenklius psichinius poky\u010dius. <\/strong>Be to, nebuvo pasteb\u0117ti jokie kraujo, inkst\u0173 ar kepen\u0173 funkcijos pakitimai, o tai yra geras \u017eenklas (12).&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>12)\u00a0 Jis gali pad\u0117ti palengvinti nerimo ir panikos sutrikimus<\/strong><\/h3>\n\n\n\n<p>Panikos sutrikimas yra sunki nerimo forma. Jei j\u016bs ar j\u016bs\u0173 pa\u017e\u012fstami ken\u010dia nuo \u0161ios \u017ealojan\u010dios b\u016bsenos, i\u0161bandykite inozitol\u012f. Dvigubo aklo tyrimo metu buvo nustatyta, kad <strong>pacientai, m\u0117nes\u012f vartoj\u0119 18 g inozitolio, per savait\u0119 patyr\u0117 ma\u017eiau panikos atak\u0173 nei tie, kurie vartojo fluvoksamin\u0105 <\/strong>(antidepresant\u0105). Inozitolio grup\u0117 taip pat patyr\u0117 ma\u017eiau pykinimo ir nuovargio atvej\u0173 &#8211; \u012fprast\u0173 fluvoksamino \u0161alutini\u0173 poveiki\u0173 (13).&nbsp;<\/p>\n\n\n\n<p>Pana\u0161\u016bs rezultatai buvo nustatyti ir kitame tyrime, kurio metu pacientams kasdien buvo duodama 12 mg inozitolio. Jie taip pat patyr\u0117 ma\u017eiau panikos atakos epizod\u0173 bei itin menk\u0105 \u0161alutin\u012f poveik\u012f (12).&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>13)\u00a0 Mio-inozitolis yra daug \u017eadantis bipolinio sutrikimo gydymas<\/strong><\/h3>\n\n\n\n<p>Nema\u017eai inozitolio tyrim\u0173 dav\u0117 daug \u017eadan\u010di\u0173 rezultat\u0173 bipolinio sutrikimo gydyme. Klinikinio tyrimo, kuriame dalyvavo 5-12 met\u0173 vaikai, kuriems nustatytas bipolinis sutrikimas, metu, tiriamiesiems buvo duodami (a) inozitolis, (b) omega 3, arba (c) inozitolis + omega 3. <strong>Grup\u0117, kuri vartojo inozitol\u012f + omega 3, parod\u0117 \u017eenkl\u0173 bipolinio sutrikimo simptom\u0173 pager\u0117jim\u0105 <\/strong>(14).&nbsp;<\/p>\n\n\n\n<p>Li\u016bdnesne gaida, pomirtiniai tyrimai, atlikti \u017emon\u0117ms, sirgusiems bipoliniu sutrikimu ir tiems, kurie i\u0161 gyvenimo pasitrauk\u0117 patys, nustat\u0117 vien\u0105 juos siejant\u012f dalyk\u0105 &#8211; vis\u0173 j\u0173 priekin\u0117je smegen\u0173 \u017eiev\u0117je buvo \u017eenkliai ma\u017eiau inozitolio (15). \u0160i smegen\u0173 dalis atsakinga u\u017e svarbius kognityvinius \u012fg\u016bd\u017eius: impuls\u0173 kontrol\u0119, sprendimus, problem\u0173 sprendim\u0105, atmint\u012f ir kalb\u0105.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>14)\u00a0 Gali pad\u0117ti gydyti li\u010dio sukelt\u0105 psoriaz\u0119<\/strong><\/h3>\n\n\n\n<p>Litis yra antimaniakinis vaistas, galintis pad\u0117ti bipoliniu sutrikimu sergantiems \u017emon\u0117ms i\u0161vengti manijos epizod\u0173. Visgi, galimas jo \u0161alutinis poveikis yra psoriaz\u0117.<\/p>\n\n\n\n<p>Cases Journal publikuotoje ataskaitoje nustatyta, kad pacient\u0117, bipolinio sutrikimo gydymui vartojusi lit\u012f, kent\u0117 nuo sunkios psoriaz\u0117s. Li\u010dio vartojimas buvo nutrauktas, o jis &#8211; pakeistas 3 g inozitolio per dien\u0105. Po 4 met\u0173, pacient\u0117 vis dar vartoja inozitol\u012f, o tiek jos bipolinis sutrikimas, tiek psoriaz\u0117 yra valdomi (16).&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>15)\u00a0 Apsaugo nuo gestacinio diabeto\u00a0<\/strong><\/h3>\n\n\n\n<p>N\u0117\u0161tumas jau i\u0161 sav\u0119s yra sud\u0117tingas periodas. Bet moteriai nusta\u010dius gestacin\u012f diabet\u0105, n\u0117\u0161tumas gali b\u016bti dar labiau komplikuotas. D\u0117l jo tiek motinai, tiek k\u016bdikiui gresia pavojus. D\u0117l savo teigiamos \u012ftakos jautrumui insulinui, <strong>inozitolis taip pat pripa\u017eintas kaip galimas gestacinio diabeto gydymas.&nbsp;<\/strong><\/p>\n\n\n\n<p>2019 m. Cureus journal publikuotas tyrimas patvirtina, kad inozitolis yra saugus papildas. Inozitolis gali suma\u017einti vir\u0161svorio turin\u010di\u0173 ar nutukusi\u0173 n\u0117\u0161\u010di\u0173j\u0173 gestacinio diabeto rizik\u0105. Be to, moterys, kuri\u0173 \u0161eimoje fiksuota antrojo tipo diabeto rizika ir\/ar PKS, taip pat gali vartoti inozitol\u012f, \u0161itaip suma\u017einant gestacinio diabeto rizik\u0105 (17).&nbsp;<\/p>\n\n\n\n<p>O \u0161tai ir gerosios naujienos &#8211; moterys, n\u0117\u0161tumo metu vartojusios mio-inozitol\u012f, taip pat <strong>pagimd\u0117 ma\u017eesnius didesnio gestacinio am\u017eiaus k\u016bdikius <\/strong>(18).<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"546\" src=\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-16-9-1024x546.jpeg\" alt=\"jis apsaugo nuo gestacinio diabeto\n\" class=\"wp-image-248850\" srcset=\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-16-9-1024x546.jpeg 1024w, https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-16-9-300x160.jpeg 300w, https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-16-9-768x410.jpeg 768w, https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-16-9-600x320.jpeg 600w, https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-16-9.jpeg 1200w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n<h3 class=\"wp-block-heading\"><strong>16)\u00a0 Gali pad\u0117ti k\u016bdikiams, ken\u010diantiems nuo respiracinio distreso sindromo<\/strong><\/h3>\n\n\n\n<p>Nei\u0161ne\u0161ioti k\u016bdikiai da\u017enai gimsta su nei\u0161sivys\u010diusiais plau\u010diais ir nuo pat gimimo patiria kv\u0117pavimo problem\u0173. Deja, buvo atlikti tik keli tyrimai, kuri\u0173 metu tiriamiesiems nei\u0161ne\u0161iotiems k\u016bdikiams buvo duodama inozitolio.<\/p>\n\n\n\n<p>Vienas ankstyvas tyrimas dav\u0117 daug \u017eadan\u010di\u0173 rezultat\u0173. Nei\u0161ne\u0161iotiems k\u016bdikiams, kuriems buvo duodamas inozitolis, <strong>reik\u0117jo ma\u017eiau mechanin\u0117s plau\u010di\u0173 ventiliacijos ir i\u0161 viso j\u0173 mir\u0117 ma\u017eiau <\/strong>(palyginus su k\u016bdikiais, kuriems nebuvo duodama inozitolio) (19).&nbsp;<\/p>\n\n\n\n<p>Visgi, naujesn\u0117 ap\u017evalga nei\u0161ne\u0161iotiems k\u016bdikiams inozitolio vartoti nerekomenduoja. Pana\u0161u, kad tyr\u0117jai nemato \u017eenklaus inozitol\u012f vartojusi\u0173 k\u016bdiki\u0173 mir\u010di\u0173, infekcij\u0173, smegen\u0173 kraujavimo, aki\u0173, plau\u010di\u0173 ir vir\u0161kinamojo trakto problem\u0173 skai\u010diaus kritimo (20).&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>17)\u00a0 Moterims padeda susidoroti su pomenopauziniu laikotarpiu<\/strong><\/h3>\n\n\n\n<p>Pasak tyrim\u0173, moterys, pereinan\u010dios \u012f pomenopauzin\u012f gyvenimo laikotarp\u012f, patiria metabolinio sindromo i\u0161sivystymo rizik\u0105. Vieno tyrimo metu buvo nustatyta, kad <strong>13,7% neseniai menopauz\u0119 i\u0161gyvenusi\u0173 moter\u0173, <\/strong>prie\u0161 menopauz\u0119 nesirgusi\u0173 diabetu ar metaboliniu sindromu, <strong>staiga i\u0161sivyst\u0117 metabolinis sindromas. <\/strong>D\u0117l \u0161ios prie\u017easties, menopauz\u0117s laikotarpiu moterys patiria didesn\u0119 \u0161irdies ir kraujagysli\u0173 lig\u0173 i\u0161sivystymo rizik\u0105 (21).&nbsp;<\/p>\n\n\n\n<p>Nesinervinkite, jei priklausote \u0161iai demografinei grupei &#8211; inozitolis yra daug \u017eadantis menopauz\u0119 patyrusi\u0173 moter\u0173 metabolinio sindromo gydymas! Tyrimas, publikuotas Menopause journal, parod\u0117, kad kasdien vartojant 2 g mio-inozitolio ir <a href=\"https:\/\/eu.intelligentlabs.org\/lt-lt\/pks-dieta\/\">sveikai maitinantis<\/a>, tiriam\u0173j\u0173 sveikata pager\u0117jo. Kraujo spaudimas, HOMA indeksas, cholesterolio ir triglicerid\u0173 lygiai &#8211; visi \u0161ie savanori\u0173 rodikliai \u017eenkliai pager\u0117jo (22).&nbsp;<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"516\" src=\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-17-9-1024x516.jpeg\" alt=\"moterys po menopauz\u0117s taip pat gali vartoti inozitol\u012f\n\" class=\"wp-image-248877\" srcset=\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-17-9-1024x516.jpeg 1024w, https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-17-9-300x151.jpeg 300w, https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-17-9-768x387.jpeg 768w, https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-17-9-600x303.jpeg 600w, https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/09\/image-17-9.jpeg 1200w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n<h3 class=\"wp-block-heading\"><strong>18)\u00a0 Mio-inozitolis gali pad\u0117ti moterims numesti svorio<\/strong><\/h3>\n\n\n\n<p>Inozitolis n\u0117ra \u017eymimas kaip produktas, skirtas svorio metimui. Bet svorio metimas yra vienas i\u0161 teigiam\u0173 pager\u0117jusio jautrumo insulinui rezultat\u0173 (23). Kaip jau su\u017einojome antrame straipsnio punkte, inozitolis pagerina jautrum\u0105 insulinui, sureguliuoadamas cukraus ir kontroliuodamas insulino lygius kraujyje. Taigi, jis gali netiesiogiai pad\u0117ti numesti svorio.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>19)\u00a0 Inozitol\u012f saugu vartoti net ir didel\u0117mis doz\u0117mis<\/strong><\/h3>\n\n\n\n<p>Vienoje m\u016bs\u0173 Chromositol-F inozitolio papildo doz\u0117je yra 2 g mio-inozitolio ir 50 mg d-chiro-inozitolio. Rekomenduojame vartoti 2 dozes per dien\u0105 maksimaliai 4 g mio-inozitolio, 100 mg d-chiro-inozitolio, 400 \u00b5g folato ir 400 \u00b5g chromo dozei.&nbsp;<\/p>\n\n\n\n<p>Tyrim\u0173 duomenimis, inozitol\u012f<strong> saugu vartoti net iki 12-18 gram\u0173 per dien\u0105<\/strong>, ypa\u010d gydant \u012fvairius psichinius sutrikimus (12, 13). <strong>\u0160alutinis poveikis yra lengvas <\/strong>net vartojant didesnes dozes (12-18 g), tarp j\u0173: duj\u0173 kaupimasis, galvos skausmas, galvos svaigimas, nuovargis ir pykinimas.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>20)\u00a0 Jis saugus net ir n\u0117\u0161\u010dioms moterims<\/strong><\/h3>\n\n\n\n<p>17-ame punkte su\u017einojome, kad inozitolis yra naudojamas n\u0117\u0161\u010di\u0173 moter\u0173 gestacinio diabeto gydymui, tad jis saugus net ir besilaukian\u010dioms moterims. Anks\u010diau jau min\u0117tame tyrime (17), pacient\u0117ms kasdien buvo duodama 4 g mio inozitolio + 400 \u00b5g folio r\u016bg\u0161ties ir neu\u017efiksuotas joks rimtas \u0161alutinis poveikis.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>21)\u00a0 Inozitolis taip pat naudingas kr\u016btimi maitinan\u010dios motinos<\/strong><\/h3>\n\n\n\n<p>Inozitolis nat\u016braliai randamas motinos piene. I\u0161 ties\u0173, pagal koncentracij\u0105, jis yra tre\u010dias po laktoz\u0117s ir gliukoz\u0117s. Inozitolio papild\u0173 vartojimas maitinimo metu bendrai yra saugus (24). Visgi, rekomenduojame b\u016bti atsargioms. Prie\u0161 prad\u0117dami vartoti inozitol\u012f (ar bet kok\u012f kit\u0105 maisto papild\u0105), pasikalb\u0117kite su savo gydytoju.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>22)\u00a0 Patogi milteli\u0173 forma<\/strong><\/h3>\n\n\n\n<p>M\u016bs\u0173 Chromositol-F inozitolio papildas parduodamas patogia milteli\u0173 forma. Kiekvienas samtelis lygus 1 dozei, tad j\u012f nesunku matuoti. J\u012f galite sumai\u0161yti su vandeniu ar savo m\u0117gstamiausiu g\u0117rimu.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>23)\u00a0 Prieinama inozitolio papild\u0173 kaina<\/strong><\/h3>\n\n\n\n<p>Kainos ir kokyb\u0117s santykio prasme inozitolio papildai yra ai\u0161k\u016bs laim\u0117tojai. Inozitolis yra saugus. Be to, jis yra naudingas ne tik PKS sergan\u010dioms moterims, bet ir \u017emon\u0117ms, ken\u010diantiems nuo kit\u0173 sutrikim\u0173. Dauguma tyrim\u0173 nustat\u0117, kad jis saugus net ir didel\u0117mis doz\u0117mis, o net ir tada galimas \u0161alutinis poveikis yra labai menkas.<\/p>\n\n\n\n<p>\u017dinant visa tai, <strong>kainos prasme efektyviausias inozitolio papildas rinkoje yra m\u016bs\u0173 Chromositol-F. <\/strong>Kiekvieno buteliuko pakanka 90 dien\u0173 (3 m\u0117nesiams). Atsi\u017evelgiant \u012f formul\u0119, u\u017e savo pinigus gausite geriausios kokyb\u0117s efektyviausi\u0105 40:1 inozitolio mi\u0161in\u012f su 5-MTHF aktyvinta folio r\u016bg\u0161timi ir maistiniu chromu!<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>I\u0161vados<\/strong><\/h2>\n\n\n\n<p><a href=\"https:\/\/eu.intelligentlabs.org\/lt-lt\/inozitolis-pks\/\"><strong>Inozitolis geriau \u017einomas kaip papildas PKS sergan\u010dioms moterims<\/strong><\/a>, bet jo nauda gali d\u017eiaugtis ir vyrai. Ap\u017evelgus vis\u0105 mio-inozitolio naud\u0105, mes tikrai suprantame, kod\u0117l jo populiarumas taip greitai auga. Komentaruose papasakokite, ar kada nors band\u0117te m\u016bs\u0173 Chromositol-F ar jei \u0161iuo metu bandote kito prekinio \u017eenklo papild\u0105. Labai nor\u0117tum\u0117me i\u0161girsti j\u016bs\u0173 inozitolio vartojimo patirt\u012f!<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong>Moksliniai \u0161altiniai<\/strong><\/h4>\n\n\n\n<p>(1) Nordio, M et al. \u201cThe 40:1 myo-inositol\/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios.\u201d European review for medical and pharmacological sciences vol. 23,12 (2019): 5512-5521. doi:10.26355\/eurrev_201906_18223<\/p>\n\n\n\n<p>(2) Bevilacqua, Arturo, and Mariano Bizzarri. \u201cInositols in Insulin Signaling and Glucose Metabolism.\u201d International journal of endocrinology vol. 2018 1968450. 25 Nov. 2018, doi:10.1155\/2018\/1968450<\/p>\n\n\n\n<p>(3) Zheng, Xiangqin et al. \u201cInositol supplement improves clinical pregnancy rate in infertile women undergoing ovulation induction for ICSI or IVF-ET.\u201d Medicine vol. 96,49 (2017): e8842. doi:10.1097\/MD.0000000000008842<\/p>\n\n\n\n<p>(4) Papaleo, Enrico et al. \u201cMyo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.\u201d Fertility and sterility vol. 91,5 (2009): 1750-4. doi:10.1016\/j.fertnstert.2008.01.088<\/p>\n\n\n\n<p>(5) Montanino Oliva, Mario et al. \u201cEffect of Myoinositol and Antioxidants on Sperm Quality in Men with Metabolic Syndrome.\u201d International journal of endocrinology vol. 2016 (2016): 1674950. doi:10.1155\/2016\/1674950<\/p>\n\n\n\n<p>(7) Raffone, Emanuela et al. \u201cInsulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women.\u201d Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology vol. 26,4 (2010): 275-80. doi:10.3109\/09513590903366996<\/p>\n\n\n\n<p>(8) Costantino, D et al. \u201cMetabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial.\u201d European review for medical and pharmacological sciences vol. 13,2 (2009): 105-10.<\/p>\n\n\n\n<p>(9) Tabrizi, Reza et al. \u201cThe effects of inositol supplementation on lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials.\u201d Lipids in health and disease vol. 17,1 123. 24 May. 2018, doi:10.1186\/s12944-018-0779-4<\/p>\n\n\n\n<p>(10) Minozzi, M et al. \u201cTreatment of hirsutism with myo-inositol: a prospective clinical study.\u201d Reproductive biomedicine online vol. 17,4 (2008): 579-82. doi:10.1016\/s1472-6483(10)60248-9<\/p>\n\n\n\n<p>(11) Pezza, Michele, and Valentina Carlomagno. \u201cInositol in Women Suffering from Acne and PCOS: a Randomized Study.\u201d Global Dermatology, vol. 4, no. 1, 2017, doi:10.15761\/god.1000203.<\/p>\n\n\n\n<p>(12) Levine, J. \u201cControlled trials of inositol in psychiatry.\u201d European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology vol. 7,2 (1997): 147-55. doi:10.1016\/s0924-977x(97)00409-4<\/p>\n\n\n\n<p>(13) Palatnik, A et al. \u201cDouble-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder.\u201d Journal of clinical psychopharmacology vol. 21,3 (2001): 335-9. doi:10.1097\/00004714-200106000-00014<\/p>\n\n\n\n<p>(14) Wozniak, Janet et al. \u201cA randomized clinical trial of high eicosapentaenoic acid omega-3 fatty acids and inositol as monotherapy and in combination in the treatment of pediatric bipolar spectrum disorders: a pilot study.\u201d The Journal of clinical psychiatry vol. 76,11 (2015): 1548-55. doi:10.4088\/JCP.14m09267<\/p>\n\n\n\n<p>(15) Shimon, H et al. \u201cReduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder.\u201d The American journal of psychiatry vol. 154,8 (1997): 1148-50. doi:10.1176\/ajp.154.8.1148<\/p>\n\n\n\n<p>(16) Kontoangelos, Konstantinos et al. \u201cAdministration of inositol to a patient with bipolar disorder and psoriasis: a case report.\u201d Cases journal vol. 3 69. 23 Feb. 2010, doi:10.1186\/1757-1626-3-69<\/p>\n\n\n\n<p>(17) Tahir, Faryal, and Zainab Majid. \u201cInositol Supplementation in the Prevention of Gestational Diabetes Mellitus.\u201d Cureus vol. 11,9 e5671. 16 Sep. 2019, doi:10.7759\/cureus.5671<\/p>\n\n\n\n<p>(18) Matarrelli, Barbara et al. \u201cEffect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial.\u201d The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians vol. 26,10 (2013): 967-72. doi:10.3109\/14767058.2013.766691<\/p>\n\n\n\n<p>(19) Hallman, M et al. \u201cRespiratory distress syndrome and inositol supplementation in preterm infants.\u201d Archives of disease in childhood vol. 61,11 (1986): 1076-83. doi:10.1136\/adc.61.11.1076<\/p>\n\n\n\n<p>(20) Howlett, Alexandra et al. \u201cInositol in preterm infants at risk for or having respiratory distress syndrome.\u201d The Cochrane database of systematic reviews ,2 CD000366. 4 Feb. 2015, doi:10.1002\/14651858.CD000366.pub3<\/p>\n\n\n\n<p>(21) Janssen, Imke et al. \u201cMenopause and the metabolic syndrome: the Study of Women\u2019s Health Across the Nation.\u201d Archives of internal medicine vol. 168,14 (2008): 1568-75. doi:10.1001\/archinte.168.14.1568<\/p>\n\n\n\n<p>(22) Giordano, Domenico et al. \u201cEffects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study.\u201d Menopause (New York, N.Y.) vol. 18,1 (2011): 102-4. doi:10.1097\/gme.0b013e3181e8e1b1<\/p>\n\n\n\n<p>(23) Clamp, L D et al. \u201cEnhanced insulin sensitivity in successful, long-term weight loss maintainers compared with matched controls with no weight loss history.\u201d Nutrition &amp; diabetes vol. 7,6 e282. 19 Jun. 2017, doi:10.1038\/nutd.2017.31<\/p>\n\n\n\n<p>(24) Brown, Laura D et al. \u201cInositol and mannose utilization rates in term and late-preterm infants exceed nutritional intakes.\u201d The Journal of nutrition vol. 139,9 (2009): 1648-52. doi:10.3945\/jn.109.109108<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Laikais, kai tokiam dideliam moter\u0173 skai\u010diui diagnozuojamas PKS (policistini\u0173 kiau\u0161id\u017ei\u0173 sindromas), inozitolio populiarumas tapo kaip niekada didelis. Jis giriamas kaip VAISTAS, skirtas ken\u010dian\u010dioms nuo PKS bei kit\u0173 sveikatos sutrikim\u0173, bet ar jis tinkamas papildas jums? Ties\u0105 pasakius, tai tur\u0117tum\u0117te nuspr\u0119sti kartu su savo gydytoju. Bet, perskait\u0119 \u0161\u012f straipsn\u012f, su\u017einosite, kad inozitolis yra sveikas papildas, net&#8230;<\/p>\n","protected":false},"author":2,"featured_media":166056,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"categories":[3015],"tags":[],"coauthors":[],"class_list":["post-232168","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mityba"],"taxonomy_info":{"category":[{"value":3015,"label":"Mityba"}]},"featured_image_src_large":["https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/07\/25-compelling-reasons-to-start-supplementing-with-myo-inositol-today-01-1024x515.jpg",1024,515,true],"author_info":{"display_name":"David Pashley","author_link":"https:\/\/eu.intelligentlabs.org\/lt-lt\/author\/david\/"},"comment_info":0,"category_info":[{"term_id":3015,"name":"Mityba","slug":"mityba","term_group":0,"term_taxonomy_id":3015,"taxonomy":"category","description":"","parent":0,"count":45,"filter":"raw","cat_ID":3015,"category_count":45,"category_description":"","cat_name":"Mityba","category_nicename":"mityba","category_parent":0}],"tag_info":false,"wpml":{"language":"lt-lt","is_original":false,"original_post_id":131427,"translations":{"bg-bg":{"id":225652,"language":"bg-bg","is_original":false},"cs-cz":{"id":218999,"language":"cs-cz","is_original":false},"de-de":{"id":71196,"language":"de-de","is_original":false},"el-cy":{"id":229470,"language":"el-cy","is_original":false},"el-gr":{"id":228308,"language":"el-gr","is_original":false},"en-gb":{"id":131427,"language":"en-gb","is_original":true},"en-ie":{"id":166548,"language":"en-ie","is_original":false},"en-mt":{"id":166063,"language":"en-mt","is_original":false},"es-es":{"id":71184,"language":"es-es","is_original":false},"et-ee":{"id":230206,"language":"et-ee","is_original":false},"fi-fi":{"id":238481,"language":"fi-fi","is_original":false},"fr-fr":{"id":71189,"language":"fr-fr","is_original":false},"hu-hu":{"id":225083,"language":"hu-hu","is_original":false},"it-it":{"id":71312,"language":"it-it","is_original":false},"lt-lt":{"id":232168,"language":"lt-lt","is_original":false},"lv-lv":{"id":230566,"language":"lv-lv","is_original":false},"nl-be":{"id":217806,"language":"nl-be","is_original":false},"nl-nl":{"id":179616,"language":"nl-nl","is_original":false},"pl-pl":{"id":193057,"language":"pl-pl","is_original":false},"ro-ro":{"id":237508,"language":"ro-ro","is_original":false},"sk-sk":{"id":238100,"language":"sk-sk","is_original":false},"sl-si":{"id":238879,"language":"sl-si","is_original":false},"sv-se":{"id":223191,"language":"sv-se","is_original":false}}},"_links":{"self":[{"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/posts\/232168","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/comments?post=232168"}],"version-history":[{"count":7,"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/posts\/232168\/revisions"}],"predecessor-version":[{"id":248904,"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/posts\/232168\/revisions\/248904"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/media\/166056"}],"wp:attachment":[{"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/media?parent=232168"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/categories?post=232168"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/tags?post=232168"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/coauthors?post=232168"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}